Alcon Research
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Alcon Research sits in the top decile of US sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count).
Alcon Research: 275 sponsored US clinical trials, 5 recruiting.
Alcon Research sponsors 275 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 248 completed. 87 of these trials are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 12 trials.
Top-decile sponsor footprint
Alcon Research ranks in the top decile of sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
248 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
275 total, page 3 of 6
DD T2 Daily Disposable Registration Trial
NCT03305770
Post Approval Study of the CyPass System
NCT03273907
A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL)
NCT03274986
Clinical Investigation of the Clareon® Intraocular Lens (IOL)
NCT03170154
Assessing Fitting Guides in Alcon Multifocal Contact Lenses
NCT03118934
Clinical Performance of a Silicone Hydrogel for Daily Disposable Wear
NCT03095027
Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction
NCT03021707
Clinical Biocompatibility Evaluation of Contact Lens Coatings
NCT03034928
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
NCT02730871
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial
NCT02700984
Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)
NCT02539654
Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study
NCT02575911
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
NCT02419508
Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration
NCT02398500
Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes
NCT02477605
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1
NCT02307682
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
NCT01699750
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
NCT01697969
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01561560
Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9
NCT01601665
Long Term Safety Protocol for the AcrySof CACHET Phakic Lens
NCT01497067
Safety and Efficacy of AL-53817 Nasal Spray Solution
NCT01454505
Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration
NCT01157065
Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)
NCT01476722
ESBA105 in Patients With Severe Dry Eye
NCT01338610
AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
NCT01484951
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
NCT01368198
Nepafenac 0.3% Two Study
NCT01318499
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
NCT01336569
Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers
NCT01484938
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
NCT01276223
Assessment of Alcon's Ocular Image Quantification System
NCT01282138
Effect of FID 114675A on Lens Wettability
NCT01342107
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
NCT01201798
Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers
NCT01211535
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
NCT01124045
Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers
NCT01187355
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)
NCT01166971
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations, and Functional Vision Correlation Following Intraocular Lens (IOL) Implantation
NCT01190631
Confirmatory Study Nepafenac 0.3%
NCT01109173
Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years
NCT01111877
Travoprost Five Day Posology Study
NCT01114893
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
NCT01102244
A Comparative Pilot Study Of High-Order Aberrations With Aspheric IOL Models SN60WF and ZCB00
NCT01105585
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
NCT01119287
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
NCT01100424
Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets
NCT01057966
Safety and Efficacy of Moxidex Otic
NCT01071902
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988
A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)
NCT01045733
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 23 |
| Phase 3 | 47 |
| Phase 4 | 40 |
Therapeutic Areas
Where Alcon Research enrollment is open (later-stage tilt)
5 recruiting of 275 indexed (2% open); 248 completed (90%).
Phase mix: 87 late (III/IV) vs 28 early (I/II) (later-stage heavy).
Top condition: Cataract (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alcon Research: open-pipeline peers nationwide
Peers matched on 275 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 275 trials (± recruiting share)
- Boston Scientific Corporation · 280 trials · 8% recruiting
- Regeneron Pharmaceuticals · 280 trials · 22% recruiting
- SWOG Cancer Research Network · 270 trials · 10% recruiting
- Novartis · 265 trials · 0% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · 2% recruiting · 55 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
- Société des Produits Nestlé (SPN) · 2% recruiting · 53 trials
- Eisai · 2% recruiting · 287 trials
Related
What to do with this Alcon Research page
275 registered trials is a research-attention snapshot, not an endorsement of Alcon Research or any single study.
- 5 of Alcon Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cataract is the condition Alcon Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Alcon Research pipeline card: 275 registered trials from official public datasets.Report a data error.